Journal Information
Scientific Letter
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
David G. Parra,
, Joanna Chorostowska-Wynimkob, Angelo Corsicoc, Cristina Esquinasd, Gerard N. McElvaneye, Annelot D. Sarkf, Maria Sucenag, Hanan Tanashh, Alice M. Turneri, Marc Miravitllesd
Corresponding author
a Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
b Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Disease, Warsaw, Poland
c Respiratory Diseases Division, IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy
d Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
e Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
f Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
g Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal
h Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, Sweden
i Institute for Applied Health Research, University of Birmingham, Birmingham, UK
Ver más